Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care
Abstract Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmac...
Saved in:
| Published in | International journal of psychiatry in clinical practice Vol. 16; no. 2; pp. 77 - 84 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Informa Healthcare
01.06.2012
Taylor & Francis |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract
Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care. |
|---|---|
| AbstractList | Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care. OBJECTIVEAnxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners.METHODSThis paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies.RESULTSFirst-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy.CONCLUSIONSThis short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care. Abstract Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care. |
| Author | Bandelow, Borwin Kasper, Siegfried Sher, Leo Zohar, Joseph Hollander, Eric Möller, Hans-Jürgen Bunevicius, Robertas |
| Author_xml | – sequence: 1 givenname: Borwin surname: Bandelow fullname: Bandelow, Borwin email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Department of Psychiatry and Psychotherapy, University of Göttingen – sequence: 2 givenname: Leo surname: Sher fullname: Sher, Leo email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Albert Einstein College of Medicine and Montefiore Medical Center – sequence: 3 givenname: Robertas surname: Bunevicius fullname: Bunevicius, Robertas email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Institute of Psychophysiology and Rehabilitation, Lithuanian University of Health Sciences – sequence: 4 givenname: Eric surname: Hollander fullname: Hollander, Eric email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Albert Einstein College of Medicine and Montefiore Medical Center – sequence: 5 givenname: Siegfried surname: Kasper fullname: Kasper, Siegfried email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Department of Psychiatry and Psychotherapy, Medical University of Vienna – sequence: 6 givenname: Joseph surname: Zohar fullname: Zohar, Joseph email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Division of Psychiatry, Chaim-Sheba Medical Center – sequence: 7 givenname: Hans-Jürgen surname: Möller fullname: Möller, Hans-Jürgen email: Borwin.Bandelow@medizin.uni-goettingen.de, Borwin.Bandelow@medizin.uni-goettingen.de organization: Department of Psychiatry and Psychotherapy, Ludwig Maximilian University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22540422$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc1uFDEQhC0URH7gDRDykQOz2B57fi4gFEFAisQFzlavp4d15LEH2xPY18gTx6PdBHHJySX56-pW1Tk58cEjIa8529Sc9e953SiuGN8IxsWmaVrO5TNyxmXLK9523UnRBalW5pScp3TDGFNNo16QUyGUZFKIM3J3tdgBnfWY6BgizTuk8w7iBCa48MsacDRHhDyhzzSMFPxfi3lPB5tCHDCmdzRsE6Zkb7EyYZoXt8rH_zIw0DmknCMsE2RraCqGKf0jrKdztBPEPTUQ8SV5PoJL-Or4XpCfXz7_uPxaXX-_-nb56boyire5EgqYMOMgsW22Ck2DA5itkrxWRkoJUo4oimp6qBWv275lQ9e32Iw9FKyrL8jbg-8cw-8FU9aTTQadA49hSZozzjspeiULKg-oiSGliKM-HlwgvbahH9rQaxv60EYZe3PcsGwnHB6HHuIvwMcDYH0Jf4I_IbpBZ9i7EMcI3ti02j-54sN_DjsEl3drjPomLNGXAJ--8R5ICLI9 |
| CitedBy_id | crossref_primary_10_1080_08039488_2018_1457178 crossref_primary_10_1097_YIC_0000000000000314 crossref_primary_10_1016_j_neulet_2016_03_001 crossref_primary_10_2174_1570159X16666180813155017 crossref_primary_10_4236_pp_2014_510109 crossref_primary_10_1016_j_psychres_2018_02_013 crossref_primary_10_1186_s12888_022_04127_3 crossref_primary_10_1016_j_mcna_2014_06_001 crossref_primary_10_1517_17425255_2013_816675 crossref_primary_10_1016_j_janxdis_2017_12_004 crossref_primary_10_1136_bmjopen_2020_046916 crossref_primary_10_1136_bmjopen_2021_055341 crossref_primary_10_3390_app12189110 crossref_primary_10_1016_j_jad_2021_09_063 crossref_primary_10_1093_ijnp_pyv047 crossref_primary_10_1517_14656566_2013_759559 crossref_primary_10_3389_fpsyt_2022_803220 crossref_primary_10_1089_jpm_2016_0261 crossref_primary_10_1590_1980_549720200029 crossref_primary_10_1111_1467_6427_12419 crossref_primary_10_4306_pi_2014_11_4_412 crossref_primary_10_1038_s41562_023_01746_y crossref_primary_10_1016_j_euroneuro_2016_02_004 crossref_primary_10_1016_j_bbr_2016_11_054 crossref_primary_10_1007_s40261_017_0528_x crossref_primary_10_1586_14737175_2014_853617 crossref_primary_10_3928_02793695_20180723_02 crossref_primary_10_2147_NDT_S335028 crossref_primary_10_3389_fpsyt_2021_686482 crossref_primary_10_1007_s00406_022_01547_w crossref_primary_10_4045_tidsskr_13_0581 crossref_primary_10_1016_j_comppsych_2024_152486 crossref_primary_10_1089_can_2019_0052 crossref_primary_10_1080_15622975_2021_2013092 crossref_primary_10_21518_2079_701X_2021_10_66_79 crossref_primary_10_1016_j_neuropharm_2018_05_009 crossref_primary_10_2478_sjecr_2019_0021 crossref_primary_10_1016_j_neuropharm_2018_10_039 crossref_primary_10_1038_s41398_022_01802_7 crossref_primary_10_1098_rstb_2013_0475 crossref_primary_10_1016_j_euroneuro_2015_12_002 crossref_primary_10_1080_14656566_2017_1359257 crossref_primary_10_1007_s00394_024_03421_y crossref_primary_10_1080_13651501_2017_1291839 crossref_primary_10_1177_0269881113512042 crossref_primary_10_33181_12062 crossref_primary_10_1111_hiv_12135 crossref_primary_10_1097_MD_0000000000005224 crossref_primary_10_2174_0929867325666171222163645 crossref_primary_10_28982_josam_627206 crossref_primary_10_3389_fphar_2019_00932 crossref_primary_10_1016_j_jpsychires_2014_05_003 crossref_primary_10_1097_01_NPR_0000475373_08924_04 crossref_primary_10_2174_0929867324666170505113631 crossref_primary_10_1038_s41572_019_0102_3 crossref_primary_10_2174_1389201021666200107113812 crossref_primary_10_3389_fnmol_2022_1056966 crossref_primary_10_1016_j_brainresbull_2016_02_008 crossref_primary_10_1186_s12875_021_01445_5 crossref_primary_10_1016_j_psychres_2022_114388 crossref_primary_10_1007_s11920_017_0847_x crossref_primary_10_3389_fphar_2021_764548 crossref_primary_10_1089_zeb_2018_1562 crossref_primary_10_1185_03007995_2015_1040750 crossref_primary_10_3390_ph17010140 crossref_primary_10_1016_j_bbr_2023_114834 crossref_primary_10_1161_STROKEAHA_117_018377 crossref_primary_10_1021_acschemneuro_1c00078 crossref_primary_10_4155_bio_2021_0185 crossref_primary_10_1016_j_ajp_2023_103847 crossref_primary_10_1016_j_jocrd_2015_03_004 crossref_primary_10_1002_da_22530 crossref_primary_10_1016_j_nurpra_2020_10_019 crossref_primary_10_1016_j_psychres_2021_113853 crossref_primary_10_1016_j_biopha_2017_04_016 crossref_primary_10_3389_fpsyt_2023_1017206 crossref_primary_10_1002_da_22895 crossref_primary_10_3389_fphar_2022_856846 crossref_primary_10_1186_s12875_023_02110_9 crossref_primary_10_1590_0102_311xen237022 crossref_primary_10_1007_s00406_017_0852_4 crossref_primary_10_1007_s40263_014_0192_0 crossref_primary_10_1002_hup_2541 crossref_primary_10_1517_17425255_2015_1021331 crossref_primary_10_1016_j_jpsychires_2020_10_028 crossref_primary_10_3389_fnhum_2023_1286865 crossref_primary_10_12968_jpar_2017_9_9_378 crossref_primary_10_1007_s40263_015_0282_7 crossref_primary_10_1186_s13063_019_4041_9 crossref_primary_10_1007_s00406_014_0563_z crossref_primary_10_3389_fpsyt_2023_1136931 crossref_primary_10_1016_j_actpha_2019_09_006 crossref_primary_10_1016_j_ctim_2019_102248 crossref_primary_10_1016_j_pnpbp_2018_01_023 crossref_primary_10_1055_a_1520_4784 crossref_primary_10_1016_j_ahj_2016_03_003 crossref_primary_10_1017_S2045796016000202 crossref_primary_10_1016_j_ejps_2021_105792 crossref_primary_10_1093_ijnp_pyv128 crossref_primary_10_1016_j_euroneuro_2020_09_636 crossref_primary_10_1007_s40520_018_0995_9 crossref_primary_10_1016_j_neubiorev_2012_09_001 crossref_primary_10_1016_j_fmc_2016_08_005 crossref_primary_10_1016_j_biopha_2023_114855 crossref_primary_10_1097_PRA_0000000000000408 crossref_primary_10_1016_j_pop_2016_02_002 crossref_primary_10_1016_j_encep_2021_08_002 crossref_primary_10_1186_1744_859X_12_41 crossref_primary_10_1007_s12325_021_01860_1 crossref_primary_10_1016_j_sapharm_2021_07_012 crossref_primary_10_1007_s00213_013_3127_4 crossref_primary_10_1097_WNF_0000000000000208 crossref_primary_10_34883_PI_2020_10_4_044 crossref_primary_10_3109_13651501_2013_784789 crossref_primary_10_1111_appy_12203 crossref_primary_10_1080_13651501_2016_1197275 crossref_primary_10_1080_14737175_2020_1740595 crossref_primary_10_1016_j_psychres_2022_114567 crossref_primary_10_1016_j_jfma_2018_01_006 crossref_primary_10_1007_s13670_014_0105_6 crossref_primary_10_1016_j_jep_2017_12_038 crossref_primary_10_3390_ijms22041662 crossref_primary_10_17116_jnevro2020120091121 crossref_primary_10_1002_14651858_CD001206_pub3 crossref_primary_10_1111_pcn_12380 crossref_primary_10_1002_wps_20038 crossref_primary_10_1016_j_eurpsy_2019_01_017 crossref_primary_10_3892_mmr_2016_5382 crossref_primary_10_17116_jnevro2020120051146 crossref_primary_10_1007_s00210_021_02116_z crossref_primary_10_1016_j_euroneuro_2018_05_006 crossref_primary_10_1097_FBP_0000000000000348 crossref_primary_10_1007_s00406_014_0523_7 crossref_primary_10_1002_gps_4088 crossref_primary_10_1080_13651501_2023_2270365 crossref_primary_10_1007_s40120_014_0016_7 crossref_primary_10_1007_s10557_020_06979_x crossref_primary_10_1016_j_brainresbull_2014_09_011 crossref_primary_10_2174_1573412915666181224123749 crossref_primary_10_1016_j_ctim_2019_02_013 crossref_primary_10_1016_j_homeo_2015_07_003 crossref_primary_10_1016_j_chbr_2021_100101 crossref_primary_10_1016_j_med_2015_07_012 crossref_primary_10_1177_0269881117705087 crossref_primary_10_1016_j_appet_2021_105599 crossref_primary_10_1097_01_NAJ_0000873444_48723_48 crossref_primary_10_3928_02793695_20230417_03 crossref_primary_10_1002_da_22337 crossref_primary_10_2119_molmed_2013_00033 crossref_primary_10_1007_s00127_017_1437_2 crossref_primary_10_1016_j_clinsp_2024_100404 crossref_primary_10_31363_2313_7053_2018_4_100_107 crossref_primary_10_1016_j_psychres_2020_113412 crossref_primary_10_1016_j_pharmthera_2014_12_004 crossref_primary_10_3390_bs3010001 crossref_primary_10_1186_s12991_020_00309_z crossref_primary_10_1038_nrn_2016_155 crossref_primary_10_1001_jama_2022_22744 crossref_primary_10_3389_fpsyt_2023_1083568 crossref_primary_10_1016_j_mehy_2013_03_030 crossref_primary_10_1590_0047_2085000000121 crossref_primary_10_3758_s13415_018_00653_4 crossref_primary_10_1007_s40266_014_0205_1 crossref_primary_10_1016_j_pop_2016_01_002 crossref_primary_10_1002_jnr_25317 crossref_primary_10_1177_0269881115598411 crossref_primary_10_3390_molecules27144528 crossref_primary_10_1007_s10942_016_0233_3 crossref_primary_10_1007_s40501_014_0020_7 crossref_primary_10_1002_wps_20089 crossref_primary_10_1016_j_pcl_2024_04_003 crossref_primary_10_1016_j_phrs_2022_106204 crossref_primary_10_3390_medicina58091163 crossref_primary_10_1080_13651501_2017_1301488 crossref_primary_10_1080_17512433_2017_1260001 crossref_primary_10_1016_j_ctcp_2018_01_008 crossref_primary_10_1080_14737175_2019_1666713 crossref_primary_10_1016_j_jpsychires_2019_01_020 crossref_primary_10_2196_mhealth_9612 crossref_primary_10_1097_YIC_0000000000000137 crossref_primary_10_1177_1078390319878878 crossref_primary_10_3389_fpsyt_2019_00129 crossref_primary_10_1093_intqhc_mzaa066 crossref_primary_10_1017_S1754470X20000112 crossref_primary_10_1097_NMD_0000000000001284 crossref_primary_10_1016_j_psychres_2021_114129 crossref_primary_10_1177_0004867412466595 crossref_primary_10_3389_fpsyg_2019_01203 crossref_primary_10_2174_0929867324666170712114445 crossref_primary_10_1002_hup_2686 crossref_primary_10_3390_ijms221810000 crossref_primary_10_1016_j_jadr_2021_100234 crossref_primary_10_1111_ajag_12298 crossref_primary_10_2217_pgs_2019_0083 crossref_primary_10_1080_13651501_2023_2231040 crossref_primary_10_1016_j_rpsm_2019_01_003 crossref_primary_10_1097_YIC_0000000000000144 crossref_primary_10_1016_j_neubiorev_2015_07_010 crossref_primary_10_1016_j_jad_2017_02_012 crossref_primary_10_1016_j_rpsmen_2019_01_003 crossref_primary_10_3390_nu14122425 crossref_primary_10_1016_j_expneurol_2023_114660 crossref_primary_10_1016_j_jpsychires_2018_03_001 crossref_primary_10_1007_s40261_016_0397_8 crossref_primary_10_1089_thy_2022_0335 crossref_primary_10_1016_j_bbr_2020_112794 crossref_primary_10_2174_0929866527666191223143230 crossref_primary_10_4103_0019_5545_196975 crossref_primary_10_1016_S0140_6736_16_30381_6 crossref_primary_10_1007_s00406_022_01390_z crossref_primary_10_1016_j_jpsychires_2019_04_013 crossref_primary_10_1080_17425255_2017_1281247 crossref_primary_10_1517_14656566_2015_1059424 crossref_primary_10_1111_gbb_12427 crossref_primary_10_1016_j_ejphar_2019_172632 crossref_primary_10_1165_rcmb_2023_0372ED crossref_primary_10_1016_j_heliyon_2018_e00688 crossref_primary_10_1016_j_pnpbp_2018_06_005 crossref_primary_10_1002_hup_2391 crossref_primary_10_1007_s10354_015_0360_y crossref_primary_10_1016_j_acu_2022_100194 crossref_primary_10_1210_EN_2015_1018 crossref_primary_10_1371_journal_pone_0208716 crossref_primary_10_21518_2079_701X_2022_16_2_76_84 crossref_primary_10_1002_14651858_CD010677_pub2 crossref_primary_10_1016_j_pbb_2015_08_003 crossref_primary_10_1002_brb3_2279 crossref_primary_10_1016_j_jpsychires_2015_02_017 crossref_primary_10_1038_s41398_021_01219_8 crossref_primary_10_1515_jbcpp_2019_0196 crossref_primary_10_1007_s40120_021_00277_w crossref_primary_10_1007_s40688_020_00301_0 crossref_primary_10_1517_13543784_2015_1005735 crossref_primary_10_1016_j_pcd_2020_07_004 crossref_primary_10_47836_mjmhs_18_s19_16 crossref_primary_10_3389_fneur_2019_00389 crossref_primary_10_1038_npp_2013_313 crossref_primary_10_1080_13543784_2019_1680638 crossref_primary_10_1080_13651501_2016_1276192 crossref_primary_10_1007_s00406_016_0684_7 crossref_primary_10_1016_j_jadr_2021_100281 crossref_primary_10_1016_j_ejphar_2024_176394 crossref_primary_10_1016_j_euroneuro_2020_01_011 crossref_primary_10_1016_j_jpsychires_2024_02_009 crossref_primary_10_1016_j_euroneuro_2015_07_024 crossref_primary_10_1056_NEJMcp1502514 crossref_primary_10_1007_s40501_017_0130_0 crossref_primary_10_1002_ejp_808 crossref_primary_10_1080_15622975_2019_1595494 crossref_primary_10_1016_j_brainresbull_2014_07_007 crossref_primary_10_17116_jnevro202112110292 crossref_primary_10_1002_cld_1200 crossref_primary_10_1111_pcn_13195 crossref_primary_10_12677_ACM_2019_94085 crossref_primary_10_9740_mhc_2022_08_225 crossref_primary_10_1080_15622975_2018_1492736 crossref_primary_10_1007_s40263_014_0162_6 crossref_primary_10_1017_neu_2020_6 crossref_primary_10_1016_j_acu_2019_09_001 crossref_primary_10_1590_0001_3765201720160177 crossref_primary_10_21518_2079_701X_2021_12_50_60 crossref_primary_10_31887_DCNS_2017_19_2_bbandelow crossref_primary_10_1016_j_neuropharm_2013_11_007 crossref_primary_10_1016_j_brat_2019_103507 crossref_primary_10_1111_exd_13959 crossref_primary_10_1093_ijnp_pyaa064 crossref_primary_10_1097_01_NPR_0000651112_76528_ed crossref_primary_10_3390_ijerph192315990 |
| Cites_doi | 10.1080/15622970802465807 |
| ContentType | Journal Article |
| Contributor | Saitz, Richard Ayuso-Gutierrez, J Kranzler, Henry R Schlaepfer, Thomas E Lader, M Vega, J Moller, Hans-Jurgen Kasper, Siegfreid Allgulander, C van Ameringen, M Cassano, G Kaiya, H Oh, K S Fineberg, N Sato, M Lopez-Ibor, J J Zhitnikova, Larisa M Rasmussen, Jill Rankans, Elmars Baranska-Rybak, Wioletta Hindmarch, I Saravane, Djea Baldwin, D Rupprecht, R Tang, S W Marazitti, D Sher, Leo Gabriels, L Fiellin, David Wong, David Bunevicius, R Thibaut, Florence Valius, Leonas Zohar, Joseph Liebowitz, M R Starcevic, V Preter, M Bandelow, Borwin Lecrubier, Y Lepine, J P Miguel, E C Klein, D F Stein, D J Hollander, Eric Bunevicius, Robertas Cubala, Wieclaw J Moore, Alison |
| Contributor_xml | – sequence: 1 givenname: Robertas surname: Bunevicius fullname: Bunevicius, Robertas – sequence: 2 givenname: Siegfreid surname: Kasper fullname: Kasper, Siegfreid – sequence: 3 givenname: Florence surname: Thibaut fullname: Thibaut, Florence – sequence: 4 givenname: Wioletta surname: Baranska-Rybak fullname: Baranska-Rybak, Wioletta – sequence: 5 givenname: Wieclaw J surname: Cubala fullname: Cubala, Wieclaw J – sequence: 6 givenname: David surname: Fiellin fullname: Fiellin, David – sequence: 7 givenname: Henry R surname: Kranzler fullname: Kranzler, Henry R – sequence: 8 givenname: Alison surname: Moore fullname: Moore, Alison – sequence: 9 givenname: Elmars surname: Rankans fullname: Rankans, Elmars – sequence: 10 givenname: Jill surname: Rasmussen fullname: Rasmussen, Jill – sequence: 11 givenname: Richard surname: Saitz fullname: Saitz, Richard – sequence: 12 givenname: Djea surname: Saravane fullname: Saravane, Djea – sequence: 13 givenname: Thomas E surname: Schlaepfer fullname: Schlaepfer, Thomas E – sequence: 14 givenname: Leo surname: Sher fullname: Sher, Leo – sequence: 15 givenname: S W surname: Tang fullname: Tang, S W – sequence: 16 givenname: Leonas surname: Valius fullname: Valius, Leonas – sequence: 17 givenname: David surname: Wong fullname: Wong, David – sequence: 18 givenname: Larisa M surname: Zhitnikova fullname: Zhitnikova, Larisa M – sequence: 19 givenname: Joseph surname: Zohar fullname: Zohar, Joseph – sequence: 20 givenname: Eric surname: Hollander fullname: Hollander, Eric – sequence: 21 givenname: Hans-Jurgen surname: Moller fullname: Moller, Hans-Jurgen – sequence: 22 givenname: Borwin surname: Bandelow fullname: Bandelow, Borwin – sequence: 23 givenname: C surname: Allgulander fullname: Allgulander, C – sequence: 24 givenname: J surname: Ayuso-Gutierrez fullname: Ayuso-Gutierrez, J – sequence: 25 givenname: D surname: Baldwin fullname: Baldwin, D – sequence: 26 givenname: R surname: Bunevicius fullname: Bunevicius, R – sequence: 27 givenname: G surname: Cassano fullname: Cassano, G – sequence: 28 givenname: N surname: Fineberg fullname: Fineberg, N – sequence: 29 givenname: L surname: Gabriels fullname: Gabriels, L – sequence: 30 givenname: I surname: Hindmarch fullname: Hindmarch, I – sequence: 31 givenname: H surname: Kaiya fullname: Kaiya, H – sequence: 32 givenname: D F surname: Klein fullname: Klein, D F – sequence: 33 givenname: M surname: Lader fullname: Lader, M – sequence: 34 givenname: Y surname: Lecrubier fullname: Lecrubier, Y – sequence: 35 givenname: J P surname: Lepine fullname: Lepine, J P – sequence: 36 givenname: M R surname: Liebowitz fullname: Liebowitz, M R – sequence: 37 givenname: J J surname: Lopez-Ibor fullname: Lopez-Ibor, J J – sequence: 38 givenname: D surname: Marazitti fullname: Marazitti, D – sequence: 39 givenname: E C surname: Miguel fullname: Miguel, E C – sequence: 40 givenname: K S surname: Oh fullname: Oh, K S – sequence: 41 givenname: M surname: Preter fullname: Preter, M – sequence: 42 givenname: R surname: Rupprecht fullname: Rupprecht, R – sequence: 43 givenname: M surname: Sato fullname: Sato, M – sequence: 44 givenname: V surname: Starcevic fullname: Starcevic, V – sequence: 45 givenname: D J surname: Stein fullname: Stein, D J – sequence: 46 givenname: M surname: van Ameringen fullname: van Ameringen, M – sequence: 47 givenname: J surname: Vega fullname: Vega, J |
| Copyright | 2012 Informa Healthcare 2012 |
| Copyright_xml | – notice: 2012 Informa Healthcare 2012 |
| CorporateAuthor | WFSBP Task Force on Anxiety Disorders, OCD and PTSD WFSBP Task Force on Mental Disorders in Primary Care |
| CorporateAuthor_xml | – name: WFSBP Task Force on Anxiety Disorders, OCD and PTSD – name: WFSBP Task Force on Mental Disorders in Primary Care |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.3109/13651501.2012.667114 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1471-1788 |
| EndPage | 84 |
| ExternalDocumentID | 10_3109_13651501_2012_667114 22540422 667114 |
| Genre | Review Article Research Support, Non-U.S. Gov't Journal Article Practice Guideline |
| GroupedDBID | --- 00X 03L 0BK 0R~ 29J 4.4 53G 5GY 5VS AAFWK AAGKR AAJNR AALIY AALUX AAMIU AAPUL AAQRR AAWTL ABBKH ABDBF ABEIZ ABEJY ABIVO ABLKL ABPTK ABUPF ACENM ACFUF ACGEJ ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AENEX AEOZL AEYQI AFKVX AFWLO AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AWYRJ BABNJ BEYMU BLEHA BOHLJ BSQBA CAG CCCUG COF CS3 CXMEQ DKSSO DU5 EAP EBD EBS EJD EMK EPL EPS ESX F5P FEDTE H13 HF~ HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL M44 M4Z O9- P2P RNANH RVRKI TFDNU TFL TFW TUS TWFNG V1S ~1N ABJNI ABLIJ ABXYU ACIEZ ALYBC CGR CUY CVF ECM EIF HVGLF NPM TBQAZ TDBHL TERGH TUROJ AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c517t-25a02cfd4e76b5ec6edacb54135c444a44fe2c4469a35137970d897e6f9ab5483 |
| ISSN | 1365-1501 |
| IngestDate | Fri Oct 25 08:44:23 EDT 2024 Fri Aug 23 00:46:14 EDT 2024 Tue Oct 15 23:41:13 EDT 2024 Tue Jul 04 18:57:17 EDT 2023 Wed Jun 21 01:44:34 EDT 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c517t-25a02cfd4e76b5ec6edacb54135c444a44fe2c4469a35137970d897e6f9ab5483 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-2 ObjectType-Feature-3 content type line 23 |
| PMID | 22540422 |
| PQID | 1011842954 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | informahealthcare_journals_10_3109_13651501_2012_667114 proquest_miscellaneous_1011842954 pubmed_primary_22540422 crossref_primary_10_3109_13651501_2012_667114 informaworld_taylorfrancis_310_3109_13651501_2012_667114 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-06-01 |
| PublicationDateYYYYMMDD | 2012-06-01 |
| PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | International journal of psychiatry in clinical practice |
| PublicationTitleAlternate | Int J Psychiatry Clin Pract |
| PublicationYear | 2012 |
| Publisher | Informa Healthcare Taylor & Francis |
| Publisher_xml | – name: Informa Healthcare – name: Taylor & Francis |
| References | Int J Psychiatry Clin Pract. 2012 Sep;16(3):242 Int J Psychiatry Clin Pract. 2013 Feb;17(1):76 APA (CIT0003) 2000 WHO. World Health Organisation (CIT0002) 1991 Bandelow B (CIT0001) 2008; 9 |
| References_xml | – volume: 9 start-page: 248 issue: 4 year: 2008 ident: CIT0001 publication-title: World J Biol Psychiatry doi: 10.1080/15622970802465807 contributor: fullname: Bandelow B – volume-title: Diagnostic and statistical manual of mental disorders year: 2000 ident: CIT0003 contributor: fullname: APA – volume-title: Clinical Descriptions and Diagnostic Guidelines year: 1991 ident: CIT0002 contributor: fullname: WHO. World Health Organisation |
| SSID | ssj0005665 |
| Score | 2.478356 |
| Snippet | Abstract
Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general... Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners.... Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. This paper is a... OBJECTIVEAnxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general... |
| SourceID | proquest crossref pubmed informaworld informahealthcare |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 77 |
| SubjectTerms | Antidepressive Agents, Tricyclic - therapeutic use Antipsychotic Agents - therapeutic use Anxiety disorders Anxiety Disorders - drug therapy Benzodiazepines - therapeutic use Dose-Response Relationship, Drug gamma-Aminobutyric Acid - analogs & derivatives gamma-Aminobutyric Acid - therapeutic use generalized anxiety disorder guidelines Histamine Antagonists - therapeutic use Humans Obsessive-Compulsive Disorder - drug therapy panic disorder pharmacological treatment Pregabalin Serotonin Uptake Inhibitors - therapeutic use social anxiety disorder Stress Disorders, Post-Traumatic - drug therapy |
| Title | Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care |
| URI | https://www.tandfonline.com/doi/abs/10.3109/13651501.2012.667114 https://www.ncbi.nlm.nih.gov/pubmed/22540422 https://search.proquest.com/docview/1011842954 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELZK94KE0PJf_mQkjmRpEsdJjltgqRBw2pX2FjmOLSqhBLWJhDjxDvCEvARXZmLHTktZWC5RZNmTOPPFM7a_GRPylHEtY5VngaxiHTAeaRgHtQiSWM95pLjK-93zd-_58oy9OU_OJ5OfI9ZS15ZH8sveuJL_0SqUgV4xSvYSmnVCoQDuQb9wBQ3D9Z90_LrDJFVIXHdswU8-FXX_-T2RHDf86889RbOyKTd7HTYlbvvCoDfwHmKkmXcfe177UNPkE2g2bbsWncnyaqNMXA2ko9vUFUgnG3u928uOo2QVnmuNzV2U5hC65ZdZa-in2YVa9DmL3cKQhdxb1bjKXQ3GXq66jWeOCzdzWCLu68pG-axXcrzsgfyRgZ5lR2qk54E3a4qUKQNLG4SpOSfQDe98BONoNFbb42Os1Wf77Els0rHis_BRyASMjjhPQxP4up2-e8esOrIjTLNQTjFIKVBKYaRcIQcRjJDZlBwcL14uTjw7ifenoLpemqhPlPN839tseVWHNufuB8cg3MnD--fZVO9VnR6S63Y6RI8Ntm-QiapvkmtmLZmaELlb5LvHOQXxFHBOd3BOHc5po6nFOXU4f0Ydyn98_ebx7WpAk4pu4ZsafPsaq5pafFPs7G1ydvLq9MUysKeJBDIJ0zaIEjGPpK6YSnmZKMlVJWSZgBOXSMaYYEyrCO54LuIkjNM8nVdZniqucwHVsvgOmdZNre4RWrI4U5mswFVOWSkjUSmO0VBsLlimQzUjwaCNwr5ZcREKZiT9TWWF_Rk3f2mZjRVbtP0ynzZn8mCzi5o-GUBQgEnBfUJRq6bDB4ZhxpAAMCN3DTpcN8D8M0wbeP-SXXxArvq_-CGZtutOPQJ3vi0fW-j_AiqF9zQ |
| link.rule.ids | 315,783,787,27938,27939 |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Guidelines+for+the+pharmacological+treatment+of+anxiety+disorders%2C+obsessive%E2%80%93compulsive+disorder+and+posttraumatic+stress+disorder+in+primary+care&rft.jtitle=International+journal+of+psychiatry+in+clinical+practice&rft.au=Bandelow%2C+Borwin&rft.au=Sher%2C+Leo&rft.au=Bunevicius%2C+Robertas&rft.au=Hollander%2C+Eric&rft.date=2012-06-01&rft.issn=1365-1501&rft.eissn=1471-1788&rft.volume=16&rft.issue=2&rft.spage=77&rft.epage=84&rft_id=info:doi/10.3109%2F13651501.2012.667114&rft.externalDBID=n%2Fa&rft.externalDocID=10_3109_13651501_2012_667114 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-1501&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-1501&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-1501&client=summon |